Zenlabs Ethica Limited · CashKonnect

About

Zenlabs Ethica Limited markets and distributes pharmaceutical products primarily in India. It markets analgesics and anti-inflammatory drugs; skin preparations; drugs for neurological and GIT disorders; ear, eye, and nasal drops; anti-diabetic, anti-depressant, anti-infective, anti-emetic, anti-hypertensive, anti-allergic, and anti-cold and cough syrups; steroids and anabolic steroids; nutraceuticals; antacids, enzymes, and appetite stimulants; ayurvedic preparations; soaps; dusting powders; soaps; and other pharmaceutical drugs. The company is also involved in the private label manufacturing of various pharmaceutical products, such as tablets, capsules, injections, syrups, and ointments; and therapeutics, such as anti-infective, anti-obesity, anti-bacterial, anti-hypertensives, anti-fungal, pain killers, and nutritional supplements. It serves customers through a network of distributors and stockists in Myanmar, Indonesia, Malaysia, Thailand, Cambodia, Vietnam, Laos, the Philippines, Singapore, Brunei, Timor-Leste, Bangladesh, and internationally. The company was formerly known as Neelkanth Technologies Limited and changed its name to Zenlabs Ethica Limited in January 2016. Zenlabs Ethica Limited was incorporated in 1993 and is based in Chandigarh, India.

Key Metrics

as of Sep 2026

Market Cap20 Cr

P/E—

Div Yield0.00 %

Book Value₹13.10

52w High₹40.00

52w Low₹16.50

Face Value₹10.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	14.18	10.58	12.43	12.43	11.48	12.99	12.72	13.35	12.36	15.33	15.60	14.06	13.57
Expenses	14.47	10.31	11.91	11.98	10.93	12.33	12.04	12.73	11.74	14.57	14.91	13.62	13.04
Operating Profit	-0.29	0.27	0.52	0.45	0.55	0.66	0.68	0.62	0.62	0.76	0.69	0.44	0.53
OPM %	-2.05	2.55	4.18	3.62	4.79	5.08	5.35	4.64	5.02	4.96	4.42	3.13	3.91
Other Income	0.00	0.12	-2.08	0.06	0.00	0.04	0.00	0.00	0.00	0.02	0.00	0.22	0.05
Depreciation	0.11	0.14	0.23	0.24	0.29	0.31	0.32	0.31	0.32	0.33	0.32	0.32	0.32
Interest	0.16	0.18	0.23	0.19	0.21	0.23	0.24	0.23	0.23	0.25	0.22	0.21	0.16
Profit before tax	-0.56	0.07	-2.02	0.08	0.05	0.16	0.12	0.08	0.07	0.20	0.15	0.13	0.10
Tax %	3.57	114.29	0.00	50.00	20.00	43.75	33.33	25.00	42.86	25.00	26.67	30.77	30.00
Net Profit	-0.57	0.00	-2.01	0.04	0.03	0.09	0.09	0.05	0.04	0.15	0.11	0.09	0.07
EPS in Rs	-0.88	0.00	-3.09	0.06	0.05	0.14	0.14	0.08	0.06	0.23	0.17	0.14	0.11

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	46.92	51.42	58.56	66.89	69.09	56.64	58.50	65.37	69.85	78.73	15.09	0.00
Expenses	45.13	48.84	56.15	63.98	66.70	54.89	59.20	63.28	68.00	77.28	14.89	0.05
Operating Profit	1.79	2.58	2.41	2.91	2.39	1.75	-0.70	2.09	1.85	1.45	0.20	-0.05
OPM %	3.82	5.02	4.12	4.35	3.46	3.09	-1.20	3.20	2.65	1.84	1.33	—
Other Income	-1.90	0.04	0.30	-0.45	0.09	0.11	0.05	0.10	0.10	0.08	-0.03	0.00
Interest	0.81	0.93	0.83	0.53	0.37	0.29	0.23	0.07	0.09	0.10	0.02	0.00
Depreciation	0.89	1.26	1.29	1.25	0.89	0.71	0.29	0.23	0.20	0.20	0.06	0.01
Profit before tax	-1.81	0.43	0.59	0.68	1.22	0.86	-1.17	1.89	1.66	1.23	0.09	-0.06
Tax %	6.63	37.21	27.12	26.47	36.07	10.47	-36.75	32.80	29.52	21.95	-88.89	16.67
Net Profit	-1.94	0.27	0.42	0.49	0.78	0.77	-0.73	1.26	1.16	0.95	0.17	-0.07
EPS in Rs	-2.98	0.41	0.65	0.75	1.20	1.18	-1.12	1.94	1.78	1.46	0.26	-0.18
Dividend Payout %	0.00	0.00	0.00	33.21	0.00	0.00	0.00	0.00	0.00	16.32	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	6.51	6.51	6.51	6.51	6.51	6.51	6.51	6.51	6.20	6.20	6.20	3.62
Reserves	2.00	3.92	3.61	3.19	2.82	2.05	0.90	1.77	0.81	-0.41	-1.41	-1.65
Borrowings	10.98	12.71	14.86	5.85	3.90	2.60	0.73	0.60	0.85	0.96	1.09	0.00
Other Liabilities	17.72	17.48	15.28	27.95	24.66	21.04	25.85	26.01	21.96	26.62	24.49	1.77
Total Liabilities	37.21	40.62	40.26	43.50	37.89	32.20	33.99	34.89	29.82	33.37	30.37	3.74
Fixed Assets	1.87	2.29	3.70	5.03	3.53	3.51	1.12	1.36	1.33	1.50	1.68	0.06
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.70	0.70	0.70	0.70	0.70	0.70	0.70	0.70	0.95	1.25	0.00
Other Assets	35.34	37.63	35.86	37.77	33.66	27.99	32.17	32.83	27.79	30.92	27.44	3.68
Total Assets	37.21	40.62	40.26	43.50	37.89	32.20	33.99	34.89	29.82	33.37	30.37	3.74

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	4.06	3.83	-9.06	1.52	-0.38	-8.41	0.45	0.80	0.36	-1.06	0.92	0.02
Cash from Investing Activity	0.00	0.14	0.11	-1.47	0.00	0.15	0.01	-0.22	-0.03	-0.02	-1.69	0.00
Cash from Financing Activity	-2.95	-3.08	8.24	0.06	0.31	-0.52	-0.03	-0.14	-0.23	-0.27	3.23	0.00
Net Cash Flow	1.11	0.88	-0.71	0.11	-0.07	-8.78	0.43	0.44	0.09	-1.35	2.47	0.02
Free Cash Flow	4.06	3.96	-9.08	-0.03	-0.41	-8.35	0.40	0.49	0.33	-1.08	-0.77	0.02
CFO/OP %	234.00	157.00	-371.00	62.00	-11.00	-475.00	-64.00	38.00	19.00	-73.00	460.00	-40.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Debtor Days	122.13	138.70	129.21	118.41	109.57	121.67	138.76	139.37	126.40	107.65	398.14	—
Inventory Days	161.14	128.43	100.05	77.85	56.05	40.46	33.95	31.23	11.12	34.42	249.62	—
Days Payable	165.22	140.00	101.21	174.04	141.30	150.28	165.31	161.27	125.88	136.41	665.46	—
Cash Conversion Cycle	118.05	127.13	128.04	22.21	24.32	11.85	7.40	9.33	11.64	5.66	-17.70	—
Working Capital Days	39.44	52.74	47.31	34.98	35.34	27.97	24.02	28.42	21.95	13.40	4.84	—
ROCE %	5.07	5.69	7.01	12.44	13.04	12.02	-11.05	24.13	23.96	21.06	9.94	-2.99

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	52.96	52.96	52.96	52.96	52.96	52.96	52.96	52.96	52.97	52.97	59.12	59.12
Public	47.04	47.05	47.04	47.04	47.03	47.04	47.04	47.04	47.02	47.01	40.88	40.87
No. of Shareholders	2,717	2,756	2,774	2,712	2,648	2,663	2,630	2,635	2,462	2,482	2,199	2,159

Corporate Actions

6 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Dividend	29 Jul 2022	01 Aug 2022	—	0.25
Bonus	11 Oct 2018	13 Oct 2018	1:20	—
Dividend	20 Sep 2017	—	—	0.25
Other	20 Sep 2012	—	—	—	General
Other	21 Sep 2011	—	—	—	General
Other	09 Sep 2010	—	—	—	General

Announcements

5 filings

Intimation Regarding Dispatch Of Letter To Shareholders Providing Web-Link Of Annual Report
04 Sep 2026 4 Sep - 33rd AGM scheduled for 29 September 2026; annual report FY2025-26 web link shared.
NOTICE OF 33RD ANNUAL GENERAL MEETING OF THE COMPANY FOR THE FINANCIAL YEAR 2025-26 4 Sep
04 Sep 2026
Reg. 34 (1) Annual Report.
04 Sep 2026 4 Sep - 33rd AGM on 29 Sep 2026; annual report sent, with auditor reappointment and object-clause amendment proposals.
Announcement under Regulation 30 (LODR)-Newspaper Publication
03 Sep 2026 3 Sep - Newspaper Advertisements published regard to 33rd Annual General Meeting is scheduled to be held on Tuesday, 29 September 2026 at 12:00 PM.
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
02 Sep 2026 2 Sep - Board approved 33rd AGM on 29 September 2026, board report, e-voting, auditor reappointment, and object clause amendment.

Shareholding Pattern

Open on BSE

Shareholding Pattern (BSE filings)

Financial Results — Filings

Open on BSE

Financial / Quarterly Results (BSE filings)

Board Filings

Open on BSE

Corporate Announcements & Board Filings (BSE)

Annual Reports

Back to all stocks